Reaktion #165065

ord-46d5cd948674461d9956f6455fb5cacc

Reaktionsgleichung

Brc1cn[nH]c1
4-bromopyrazole
N[C@@H]1CCCC[C@H]1N
trans-1,2-cyclohexanediamine
O=C([O-])[O-].[K+].[K+]
potassium carbonate
CC(C)(C)C(=O)Nc1ncccc1I
N-(3-iodo-pyridin-2-yl)-2,2-dimethyl-propionamide
CC(C)(C)C(=O)Nc1ncccc1-n1cc(Br)cn1
title compound
Ausbeute 53.4%
CC(C)(C)C(=O)Nc1ncccc1-n1cc(Br)cn1
N-(3-(4-Bromo-pyrazol-1-yl)-pyridin-2-yl)-2,2-dimethyl-propionamide
Ausbeute 53.4%

Lösungsmittel

Reaktionsbedingungen

Temperatur
110°CELSIUS
Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    EinengenThe reaction mixture was concentrated under a reduced pressure
  2. 2
    SonstigeThe residue was purified by NH silica gel column chromatography (ethyl acetate:heptane=2:1)

Vorschrift

To a mixture of N-(3-iodo-pyridin-2-yl)-2,2-dimethyl-propionamide (380 mg, 1.2 mmol) described in Manufacturing Example 39-1-2 and toluene (10 mL) were added 4-bromopyrazole (160 mg, 1.1 mmol), copper (I) iodide (11 mg, 0.056 mmol), trans-1,2-cyclohexanediamine (26 mg, 0.22 mmol) and potassium carbonate (340 mg, 2.5 mmol) at room temperature, which was stirred overnight at 110° C. The reaction mixture was concentrated under a reduced pressure. The residue was purified by NH silica gel column chromatography (ethyl acetate:heptane=2:1) to obtain the title compound (190 mg, 52%).

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US08841327B2uspto-grants-2014_09